Patient Information: Summary of Product Characteristics
Cardyl Plus10 mg/20 mg film-coated tablets EFG
Cardyl Plus 10 mg/40 mg film-coated tablets EFG
Cardyl Plus 10 mg/80 mg film-coated tablets EFG
Ezetimibe/Atorvastatin
Read the entire summary of product characteristics carefully before you start taking this medicine because it contains important information for you.
Contents of the Summary of Product Characteristics
Ezetimibe/Atorvastatin is a medicine that lowers high cholesterol levels. Cardyl Plus contains ezetimibe and atorvastatin.
Ezetimibe/Atorvastatin is used in adults to lower total cholesterol, "bad" cholesterol (LDL cholesterol), and substances called triglycerides that circulate in the blood. Additionally, Cardyl Plus raises the levels of "good" cholesterol (HDL cholesterol).
Ezetimibe/Atorvastatin works by reducing cholesterol in two ways. It reduces the cholesterol absorbed in the digestive tract, as well as the cholesterol produced by the body itself.
Cholesterol is one of the fatty substances found in the bloodstream. Your total cholesterol is made up mainly of LDL and HDL cholesterol.
LDL cholesterol is often called "bad" cholesterol because it can build up in the walls of your arteries, forming plaques. Over time, this buildup of plaque can cause the arteries to narrow, slowing or blocking the flow of blood to vital organs such as the heart and brain. This interruption of blood flow can trigger a heart attack or stroke.
HDL cholesterol is often called "good" cholesterol because it helps prevent "bad" cholesterol from building up in the arteries and protects them from heart disease.
Triglycerides are another type of fat found in your blood that can increase the risk of heart disease.
Cardyl Plus is used in patients who cannot control their cholesterol levels by diet alone. While taking this medicine, you should follow a cholesterol-lowering diet.
Ezetimibe/Atorvastatin is used, along with a cholesterol-lowering diet, if you have:
Cardyl Plus does not help you lose weight.
Consult your doctor or pharmacist before starting to take ezetimibe/atorvastatin
Contact your doctor as soon as possible if you experience unexplained muscle pain, tenderness, or muscle weakness while taking Cardyl Plus.This is because, in rare cases, muscle problems can be serious, including muscle breakdown causing kidney damage. Atorvastatin is known to cause muscle problems, and muscle problems have also been reported with ezetimibe.
Also, inform your doctor or pharmacist if you have persistent muscle weakness. Further tests and medications may be necessary to diagnose and treat this problem.
Consult your doctor or pharmacist before starting to take Cardyl Plus:
If you are in any of the above situations (or are unsure), consult your doctor before starting to take ezetimibe/atorvastatin, as your doctor will need to perform a blood test before starting your treatment with ezetimibe/atorvastatin, and possibly during treatment, to predict the risk of muscle side effects. It is known that the risk of muscle side effects, e.g., rhabdomyolysis, increases when certain medications are taken simultaneously (see section 2 "Other medicines and Cardyl Plus").
While you are taking this medicine, your doctor will check if you have diabetes or are at risk of developing diabetes. This risk of diabetes increases if you have high levels of sugars and fats in the blood, are overweight, and have high blood pressure.
Tell your doctor about all your medical problems, including allergies.
The combined use of Cardyl Plus and fibrates (certain cholesterol-lowering medications) should be avoided, as the combined use of Cardyl Plus and fibrates has not been studied.
Ezetimibe/Atorvastatin is not recommended for children and adolescents.
Tell your doctor or pharmacist if you are taking, have recently taken, or might take any other medicines, including those obtained without a prescription.
There are some medicines that can affect the way Cardyl Plus works or that can be affected by Cardyl Plus (see section 3). This type of interaction could decrease the effectiveness of one or both medicines. On the other hand, it could also increase the risk or severity of side effects, including a serious disorder in which muscle tissue is destroyed, known as "rhabdomyolysis," which is described in section 4:
See section 3 for instructions on how to take Cardyl Plus. Please note the following:
Grapefruit juice
Do not drink more than one or two small glasses of grapefruit juice per day, as large amounts of grapefruit juice can alter the effects of Cardyl Plus.
Alcohol
Avoid excessive alcohol consumption while taking this medicine. For more details, see section 2 "Warnings and precautions".
Do not take Cardyl Plus if you are pregnant, trying to become pregnant, or think you may be pregnant. Do not take ezetimibe/atorvastatin if you can become pregnant, unless you use reliable contraceptive methods. If you become pregnant while taking Cardyl Plus, stop taking it immediately and inform your doctor.
Do not take Cardyl Plus if you are breastfeeding.
The safety of ezetimibe/atorvastatin during pregnancy and breastfeeding has not yet been established. Consult your doctor or pharmacist before taking this medicine.
Cardyl Plus is not expected to affect your ability to drive or use machines. However, it should be noted that some people experience dizziness after taking Cardyl Plus.
The tablets of Cardyl Plus contain a sugar called lactose. If your doctor has told you that you have an intolerance to some sugars, contact them before taking this medicine.
This medicine contains less than 1 mmol of sodium (23 mg) per tablet; i.e., it is essentially "sodium-free".
Follow the instructions for administration of this medicine exactly as prescribed by your doctor. Your doctor will determine the appropriate dose per tablet for you, depending on your current treatment and personal risk situation. In case of doubt, consult your doctor or pharmacist again.
How much to take
The recommended dose is one tablet of ezetimibe/atorvastatin once a day by mouth.
Method of administration
Take ezetimibe/atorvastatin at any time of day. You can take it with or without food.
If your doctor has prescribed ezetimibe/atorvastatin along with colestyramine or any other bile acid sequestrant (medicines that lower cholesterol levels), you should take Cardyl Plus at least 2 hours before or 4 hours after taking the bile acid sequestrant.
Consult your doctor or pharmacist.
In case of overdose or accidental ingestion, consult your doctor or pharmacist or call the Toxicology Information Service, phone: 91 562 04 20, indicating the medicine and the amount ingested.
Do not take an extra dose; the next day, take your usual amount of ezetimibe/atorvastatin at the usual time. If you have any further questions about the use of this medicine, ask your doctor or pharmacist.
Like all medicines, this medicine can cause adverse effects, although not all people suffer from them.
If you experience any of the following serious adverse effects or symptoms, stop taking your tablets and immediately inform your doctor, or go to the emergency department of the nearest hospital
Consult your doctor as soon as possible if you experience problems associated with the unexpected or unusual appearance of bleeding or bruising, as this fact may indicate a liver condition.
The following frequent adverse effects have been reported (may affect up to 1 in 10 patients):
The following infrequent adverse effects have been reported (may affect up to 1 in 100 patients):
Additionally, the following adverse effects have been reported in people taking Cardyl Plus, ezetimibe, or atorvastatin tablets:
Consult your doctor if you experience weakness in your arms or legs that worsens after periods of activity, double vision, or drooping eyelids, difficulty swallowing, or shortness of breath.
Possible Adverse Effects Reported with Some Statins
If you experience any type of adverse effect, consult your doctor, pharmacist, or nurse, even if it is a possible adverse effect that is not listed in this leaflet. You can also report them directly through the Spanish Pharmacovigilance System for Human Use Medicines: https://www.notificaram.es. By reporting adverse effects, you can contribute to providing more information on the safety of this medicine.
Keep this medicine out of the sight and reach of children.
Do not use this medicine after the expiration date that appears on the carton or packaging after "CAD" or "EXP". The expiration date is the last day of the month indicated.
This medicine does not require special storage conditions.
Medicines should not be thrown away through wastewater or household waste. Deposit the packaging and medicines you no longer need at the SIGRE collection point in your pharmacy. In case of doubt, ask your pharmacist how to dispose of the packaging and medicines you no longer need. This way, you will help protect the environment.
Composition of Cardyl Plus
The active ingredients are ezetimibe and atorvastatin. Each film-coated tablet contains
10 mg of ezetimibe and 20 mg, 40 mg, or 80 mg of atorvastatin (as atorvastatin calcium trihydrate).
The other ingredients are: calcium carbonate; anhydrous colloidal silica; sodium croscarmellose; hydroxypropylcellulose; lactose monohydrate; povidone; magnesium stearate; microcrystalline cellulose; polysorbate 80; sodium lauryl sulfate.
The tablet coating contains: hypromellose, lactose monohydrate, titanium dioxide (171), macrogol, and talc.
See also section 2 "Cardyl plus contains lactose" and "Cardyl plus contains sodium".
Appearance of the Product and Package Contents
Film-coated tablets, biconvex, capsule-shaped, and white to off-white in color.
Cardyl Plus 10 mg/20 mg tablets are engraved with "2T" on one side.
Cardyl Plus 10 mg/40 mg tablets are engraved with "4T" on one side.
Cardyl Plus 10 mg/80 mg tablets are engraved with "8T" on one side.
Package sizes:
Packaging of 10, 30, 90, and 100 film-coated tablets in blisters.
Only some package sizes may be marketed.
Marketing Authorization Holder and Manufacturer
Marketing Authorization Holder:
Viatris Healthcare Limited
Damastown Industrial Park
Mulhuddart, Dublin 15
Dublin
Ireland
Manufacturer:
Delorbis Pharmaceutical Ltd
17 Athinon Street,
Ergates Industrial Area,
2643 Ergates Lefkosia,
Cyprus
You can request more information about this medicine by contacting the local representative of the marketing authorization holder:
Viatris Pharmaceuticals, S.L.
C/ General Aranaz, 86
28027 - Madrid
Spain
This medicine is authorized in the Member States of the European Economic Area under the following names:
Belgium: Myatorlip 10mg/10mg; 10mg/20mg; 10mg/40mg; 10mg/80mg film-coated tablets
Croatia: Sortis Plus 10mg/10mg; 10mg/20mg; 10mg/40mg; 10mg/80mg film-coated tablets
Spain: Cardyl Plus 10mg/20mg; 10mg/40mg; 10mg/80mg film-coated tablets
EFG
Luxembourg: Myatorlip 10mg/10mg; 10mg/20mg; 10mg/40mg; 10mg/80mg film-coated tablets
Netherlands: Ezetimibe/Atorvastatine Mylan 10mg/10mg; 10mg/20mg; 10mg/40mg; 10mg/80mg film-coated tablets
Portugal: Atorvastatina + Ezetimiba Mylan
Romania: Sortis Plus 10mg/10mg; 10mg/20mg; 10mg/40mg; 10mg/80mg tablets
Detailed information about this medicine is available on the website of the Spanish Agency for Medicines and Health Products (AEMPS) http://www.aemps.gob.es
The average price of CARDYL PLUS 10 mg/20 mg FILM-COATED TABLETS in October, 2025 is around 23.39 EUR. Prices may vary depending on the region, pharmacy, and whether a prescription is required. Always check with a local pharmacy or online source for the most accurate information.